رئة مربي الطيور غير التليفية بعد فشل مثبطات المناعة الموفرة للستيرويد في تثبيت وظائف الرئة

References

1. Recently published international diagnostic guidelines recommend HP classification into fibrotic or nonfibrotic phenotypes based on the presence or absence of radiological and/or histopathological fibrosis, supported by the observation that pulmonary fibrosis conveys important prognostic and treatment implications.
2. Moderate-to-high dose systemic corticosteroids would usually be considered for HP patients with features of inflammation (e.g., GGO on HRCT, BAL lymphocytosis, well-documented exposure with acute or sub-acute symptom onset).
3. There is case series-level evidence only for third-line agents including rituximab in HP.

DOI: 10.1111/resp.14847